生物股份
(600201)
| 流通市值：138.41亿 | | | 总市值：138.41亿 |
| 流通股本：11.12亿 | | | 总股本：11.12亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,042,405,531.87 | 619,568,676.18 | 351,572,845.58 | 1,255,455,757.88 |
| 营业收入 | 1,042,405,531.87 | 619,568,676.18 | 351,572,845.58 | 1,255,455,757.88 |
| 二、营业总成本 | 907,899,347.17 | 579,263,137.46 | 283,520,948.56 | 1,120,584,380.13 |
| 营业成本 | 480,738,766.8 | 295,879,156.45 | 159,875,470.45 | 579,326,374.56 |
| 税金及附加 | 14,143,677.97 | 11,101,405.55 | 2,783,880.33 | 21,829,242.01 |
| 销售费用 | 220,622,691.54 | 133,284,207.31 | 52,718,290.67 | 289,209,903.79 |
| 管理费用 | 134,381,613.4 | 90,211,784.32 | 41,099,013.16 | 143,129,426.2 |
| 研发费用 | 96,015,120.05 | 73,427,942.73 | 39,703,032.62 | 136,817,966.01 |
| 财务费用 | -38,002,522.59 | -24,641,358.9 | -12,658,738.67 | -49,728,532.44 |
| 其中:利息费用 | 375,065.18 | 879,090.45 | 443,915.94 | 5,502,260.49 |
| 其中:利息收入 | 38,994,533.91 | 26,009,377.23 | 13,090,375.82 | 55,355,612.38 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,511,244.77 | -110,945.37 | -87,588.45 | 2,815,245.68 |
| 加:投资收益 | 16,516,192.29 | 15,045,803.24 | 13,980,823.8 | -12,301,592.56 |
| 资产处置收益 | 8,391,965.63 | -51,912.84 | -59,901.27 | 2,575,161.17 |
| 资产减值损失(新) | -2,600,444.29 | -4,373,994.18 | 2,019,000.92 | -31,072,325.92 |
| 信用减值损失(新) | -13,453,504.16 | -560,606.56 | 1,336,853.59 | -30,658,471.01 |
| 其他收益 | 34,447,656.97 | 24,111,618.28 | 10,860,501.5 | 58,434,975.42 |
| 四、营业利润 | 179,319,295.91 | 74,365,501.29 | 96,101,587.11 | 124,664,370.53 |
| 加:营业外收入 | 199,800.79 | 58,885.79 | 28,038.93 | 1,517,702.83 |
| 减:营业外支出 | 355,329.82 | 274,873.22 | 164,166.5 | 1,271,758.57 |
| 五、利润总额 | 179,163,766.88 | 74,149,513.86 | 95,965,459.54 | 124,910,314.79 |
| 减:所得税费用 | 19,964,963.83 | 15,474,097.41 | 18,762,845.19 | 20,756,222.15 |
| 六、净利润 | 159,198,803.05 | 58,675,416.45 | 77,202,614.35 | 104,154,092.64 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 159,198,803.05 | 58,675,416.45 | 77,202,614.35 | 104,154,092.64 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 161,312,813.38 | 60,424,024.24 | 76,481,084.9 | 108,985,186.46 |
| 少数股东损益 | -2,114,010.33 | -1,748,607.79 | 721,529.45 | -4,831,093.82 |
| 扣除非经常损益后的净利润 | 114,837,411.65 | 32,190,604.29 | 59,015,598.31 | 49,487,344.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.15 | 0.06 | 0.07 | 0.1 |
| (二)稀释每股收益 | 0.15 | 0.06 | - | - |
| 八、其他综合收益 | 95,422,007.86 | 95,500,207.21 | 41,680,353.86 | -74,369,451.27 |
| 归属于母公司股东的其他综合收益 | 95,452,764.53 | 95,500,168.59 | 41,680,340.64 | -74,358,315.24 |
| 九、综合收益总额 | 254,620,810.91 | 154,175,623.66 | 118,882,968.21 | 29,784,641.37 |
| 归属于母公司股东的综合收益总额 | 256,765,577.91 | 155,924,192.83 | 118,161,425.54 | 34,626,871.22 |
| 归属于少数股东的综合收益总额 | -2,144,767 | -1,748,569.17 | 721,542.67 | -4,842,229.85 |
| 公告日期 | 2025-10-28 | 2025-08-20 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |